The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-scale tumor sequencing has revolutionized the identification of somatic driver alterations but has had limited impact on the identification of cancer predisposition genes (CPGs). Here we present a statistical method, ALFRED, that tests Knudson’s two-hit hypothesis to systematically identify CPGs from cancer genome data. Applied to ~10, 000 tumor exomes the approach identifies known and putative CPGs – including the chromatin modifier NSD1 – that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH). Rare germline variants in these genes contribute substantially to cancer risk, including t...
Cancer research, like many areas of science, is adapting to a new era characterized by increasing qu...
Multigene panels are routinely used to assess for predisposing germline mutations in families at hig...
The implementation of next-generation genomic sequencing has exploded over the past dozen years. Lar...
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-s...
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-...
Background: The landscape of cancer-predisposing genes has been extensively investigated in the last...
Genome-wide association studies (GWASs) have unraveled a large number of cancer risk alleles. Unders...
Background: Multigene panels are routinely used to assess for predisposing germline mutations in fam...
Cancer, like many common disorders, has a complex etiology, often with a strong genetic component an...
Cancer, a disease of the genome, is caused by a combination of germline predisposing variants and ac...
Purpose: In many children with cancer and characteristics suggestive of a genetic predisposition syn...
In the past decade, tumor-germline next generation sequencing has become a routine part of personali...
Genome-wide association studies (GWASs) have unraveled a large number of cancer risk alleles. Unders...
Most cancers are caused by a combination of inherited germline variants and somatically acquired m...
Genome-wide association studies (GWAS) have found hundreds of single-nucleotide polymorphisms (SNP) ...
Cancer research, like many areas of science, is adapting to a new era characterized by increasing qu...
Multigene panels are routinely used to assess for predisposing germline mutations in families at hig...
The implementation of next-generation genomic sequencing has exploded over the past dozen years. Lar...
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-s...
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-...
Background: The landscape of cancer-predisposing genes has been extensively investigated in the last...
Genome-wide association studies (GWASs) have unraveled a large number of cancer risk alleles. Unders...
Background: Multigene panels are routinely used to assess for predisposing germline mutations in fam...
Cancer, like many common disorders, has a complex etiology, often with a strong genetic component an...
Cancer, a disease of the genome, is caused by a combination of germline predisposing variants and ac...
Purpose: In many children with cancer and characteristics suggestive of a genetic predisposition syn...
In the past decade, tumor-germline next generation sequencing has become a routine part of personali...
Genome-wide association studies (GWASs) have unraveled a large number of cancer risk alleles. Unders...
Most cancers are caused by a combination of inherited germline variants and somatically acquired m...
Genome-wide association studies (GWAS) have found hundreds of single-nucleotide polymorphisms (SNP) ...
Cancer research, like many areas of science, is adapting to a new era characterized by increasing qu...
Multigene panels are routinely used to assess for predisposing germline mutations in families at hig...
The implementation of next-generation genomic sequencing has exploded over the past dozen years. Lar...